Inventor · disambiguated record
Alexander Li
Also filed as: LI ALEXANDER · LI ALEXANDER D Q · LI ALEXANDER DEQUAN
10 granted patents·9 pending applications·20 citations·filing 2004–2025
85Inventor score
Top patents by PatentIndex Score
19 records- 0195US11180757B117β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Nov 23, 2021·3 cites·30 claims
- 0294US10787647B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2018·Granted Sep 29, 2020·10 cites·52 claims
- 0392US11753628B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2022·Granted Sep 12, 2023·1 cites·26 claims
- 0486US2024141305A1Hsd17b13 variants and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0584US11845963B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2018·Granted Dec 19, 2023·1 cites·12 claims
- 0684US11485958B2HSD17B13 variants and uses thereofREGENERON PHARMA·Filed 2020·Granted Nov 1, 2022·1 cites·40 claims
- 0780US2023031669A1Hsd17b13 variants and uses thereofREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0876US2025333737A117ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOFREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0974US2025170226A1Methods Of Treating Skin Cancer With Histidine Ammonia-Lyase (HAL) AgonistsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1070US12359201B217ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Jul 15, 2025·0 cites·39 claims
- 1166US12186378B2Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonistsREGENERON PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·10 claims
- 1264US7238792B2Foldable polymers as probesUNIV WASHINGTON·Filed 2004·Granted Jul 3, 2007·4 cites·57 claims
- 1363US11435287B2Spectroscopic measurements and super-resolution imaging by supracenceUNIV WASHINGTON STATE·Filed 2019·Granted Sep 6, 2022·0 cites·39 claims
- 1460US2023025878A1Methods Of Treating A Metabolic Disorder With Mitogen-Activated Protein Kinase Kinase Kinase 15 (MAP3K15) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1560US2023041060A1Treatment of Varicose Veins With Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) AgonistsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1657US2023074721A1Treatment Of Inflammatory Diseases With RAS Protein Activator Like 3 (RASAL3) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1756US2023023182A1Methods Of Treating Asthma With Solute Carrier Family 27 Member 3 (SLC27A3) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1855US7556967B2Foldable polymers as probesUNIV WASHINGTON·Filed 2007·Granted Jul 7, 2009·0 cites·1 claims
- 1955US2023027007A1Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexander Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →